H.C. Wainwright Upgrades Aclaris Therapeutics to Buy
H.C. Wainwright upgrades Aclaris Therapeutics (ACRS) to Buy, setting a $20 price target following an exclusive license deal with Biosion. Explore investment opportunities in biotech growth.
Topic
Growth
A collection of 177 issues
Rumble Allocates $250 Million for Expansion and Self Tender Offer
Rumble to invest $250 million in growth initiatives, with remaining funds directed towards a self tender offer. Discover Rumble's strategic financial moves.
Broadcom's AI Revenue to Surge 65% in Q1
Broadcom anticipates a 65% increase in AI revenue, reaching $3.8 billion in fiscal Q1. Discover the factors driving this impressive growth in AI technology.
Eli Lilly Surges $170 Billion in Market Value with Zepbound
Eli Lilly & Co. skyrockets over $170 billion in market value as demand for its Zepbound drug soars, showcasing impressive growth and investment potential.
Eli Lilly Stock Surges 32% YTD, Reaches $729 Billion Market Cap
Eli Lilly's stock performance shines with a 32% year-to-date increase, pushing its market capitalization to a remarkable $729 billion. Explore this growth trajectory.
MetLife Eyes Expansion in Asset Management Through Acquisition
MetLife is advancing its growth strategy by acquiring new asset management capabilities, highlighting the ongoing M&A trend in the financial sector.
Aviva Set to Become UK's Largest Motor Insurer
Aviva's strategic merger could make it the UK's top motor insurer, surpassing Admiral and potentially doubling its market share. Explore the growth in the insurance sector.